Point72 Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$540M |
| 2 |
Applied Materials
AMAT
|
+$417M |
| 3 |
Analog Devices
ADI
|
+$307M |
| 4 |
Amer Sports
AS
|
+$295M |
| 5 |
RTX Corp
RTX
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$966M |
| 2 |
Microsoft
MSFT
|
+$724M |
| 3 |
Coherent
COHR
|
+$632M |
| 4 |
NVIDIA
NVDA
|
+$441M |
| 5 |
Biogen
BIIB
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.36% |
| 2 | Consumer Discretionary | 9.65% |
| 3 | Healthcare | 8.65% |
| 4 | Industrials | 7.85% |
| 5 | Financials | 6.43% |
Similar funds
Point72 Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Point72 Asset Management held 4,705 positions worth $78.1B, down 13% from $89.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Point72 Asset Management withdrew a net $12.4B in Q1 2026, closing 1,001 positions and reducing 1,426 holdings. Its most notable exit was PepsiCo, an estimated $367M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Point72 Asset Management opened a new position in PPL Corp worth $216M.
- Point72 Asset Management's largest Q1 2026 buy was PPL Corp: 5,659,324 shares worth $216M.
- Point72 Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $540M increase.
- Point72 Asset Management's biggest Q1 2026 reduction was TSMC, cutting an estimated $966M.
- Point72 Asset Management fully exited PepsiCo in Q1 2026, selling an estimated $367M.
- Point72 Asset Management's ten largest holdings make up 11% of its $78.1B portfolio in Q1 2026.
- Point72 Asset Management opened 851 new positions and closed 1,001 in Q1 2026.
- Point72 Asset Management's portfolio value fell 13% quarter-over-quarter to $78.1B.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.